Boustead acquires UroMedTech: robotics for prostate diagnosis
Boustead Singapore invests in robotic urological diagnostics with the acquisition of UroMedTech
The Southeast Asian engineering giant Boustead Singapore has acquired 60% of UroMedTech, a developer of robotic technologies for prostate cancer diagnosis. The operation marks the’